BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33957278)

  • 1. Cellulitis risk factors for patients with primary or secondary lymphedema.
    Vignes S; Poizeau F; Dupuy A
    J Vasc Surg Venous Lymphat Disord; 2022 Jan; 10(1):179-185.e1. PubMed ID: 33957278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for developing upper limb cellulitis after breast cancer treatment.
    Engin O; Sahin E; Saribay E; Dilek B; Akalin E
    Lymphology; 2022; 55(2):77-83. PubMed ID: 36170582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons Between Cancer-Related and Noncancer-Related Lymphedema: An Overview of New Patients Referred to a Specialized Hospital-Based Center in Canada.
    Shallwani SM; Hodgson P; Towers A
    Lymphat Res Biol; 2017 Mar; 15(1):64-69. PubMed ID: 28135124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellulitis after axillary lymph node dissection for carcinoma of the breast.
    Simon MS; Cody RL
    Am J Med; 1992 Nov; 93(5):543-8. PubMed ID: 1364813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cellulitis in patients with lymphedema: a case-controlled study.
    Teerachaisakul M; Ekataksin W; Durongwatana S; Taneepanichskul S
    Lymphology; 2013 Sep; 46(3):150-6. PubMed ID: 24645538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the efficacy of vascularised lymph node transfer in reducing limb volume and cellulitis episodes in patients with cancer treatment-related lymphoedema.
    Ward J; King I; Monroy-Iglesias M; Russell B; van Hemelrijck M; Ramsey K; Khan AA
    Eur J Cancer; 2021 Jul; 151():233-244. PubMed ID: 34092349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialized consultations in a hospital-based referral center for patients suspected of having limb lymphedema: Impact on diagnosis.
    Vignes S; Vidal F; Arrault M
    Vasc Med; 2017 Aug; 22(4):331-336. PubMed ID: 28633618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency?
    Sharkey AR; King SW; Ramsden AJ; Furniss D
    Microsurgery; 2017 May; 37(4):348-353. PubMed ID: 27661464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulitis in patients with chronic lower-limb lymphedema due to HIV-related Kaposi sarcoma.
    Volkow-Fernández P; Islas-Muñoz B; Alatorre-Fernández P; Cornejo-Juárez P
    Int J STD AIDS; 2022 Mar; 33(3):296-303. PubMed ID: 34965797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of quality of life changes in patients with lower extremity lymphedema using an advanced pneumatic compression device at home.
    Maldonado TS; Rokosh RS; Padberg F; Rotella V; Miller H; Nassiri N; Jacobowitz G; Berland T; Sadek M; Barfield ME
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):745-752. PubMed ID: 33137494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema.
    Rodriguez JR; Hsieh F; Huang CT; Tsai TJ; Chen C; Cheng MH
    J Surg Oncol; 2020 Jan; 121(1):25-36. PubMed ID: 31264724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined conservative treatment and lymphatic venous anastomosis for severe lower limb lymphedema with recurrent cellulitis.
    Mihara M; Hara H; Tsubaki H; Suzuki T; Yamada N; Kawahara M; Murai N
    Ann Vasc Surg; 2015 Aug; 29(6):1318.e11-5. PubMed ID: 26146234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Dermal Hypoechogenicity and Cellulitis History in Patients with Lower Extremity Lymphedema: A Cross-Sectional Observational Study.
    Dai M; Minematsu T; Ogawa Y; Kawamoto A; Nakagami G; Sanada H
    Lymphat Res Biol; 2022 Aug; 20(4):376-381. PubMed ID: 34762544
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of Cellulitis among Children with Primary Lymphedema.
    Quéré I; Nagot N; Vikkula M
    N Engl J Med; 2018 May; 378(21):2047-2048. PubMed ID: 29791815
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of toes as an integrated part of infection control for advanced lower limb lymphedema.
    Yildirim MEC; Chen SH; Weng HC; Mousavi SA; Chen HC
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):168-173. PubMed ID: 32900654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary limb lymphedema].
    Vignes S
    Presse Med; 2010 Dec; 39(12):1287-91. PubMed ID: 20850263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Scintigraphic Predictors of Primary Lower Limb Lymphedema-Volume Reduction During Complete Decongestive Physical Therapy.
    Vignes S; Simon L; Benoughidane B; Simon M; Fourgeaud C
    Phys Ther; 2020 May; 100(5):766-772. PubMed ID: 31944248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellulitis Recurrence Score: a tool for predicting recurrence of lower limb cellulitis.
    Tay EY; Fook-Chong S; Oh CC; Thirumoorthy T; Pang SM; Lee HY
    J Am Acad Dermatol; 2015 Jan; 72(1):140-5. PubMed ID: 25443627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Vascularized Lymph Node Transplantation for Treatment of Lymphedema.
    Schaverien MV; Asaad M; Selber JC; Liu J; Chen DN; Hall MS; Butler CE
    J Am Coll Surg; 2021 Jun; 232(6):982-994. PubMed ID: 33766726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased breast cancer-related lymphedema volume.
    Vignes S; Arrault M; Dupuy A
    Acta Oncol; 2007; 46(8):1138-42. PubMed ID: 17851861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.